Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Celgene resubmits MS drug, ozanimod, to FDA

pharmatimesMarch 28, 2019

Tag: FDA , Celgene , ozanimod

PharmaSources Customer Service